Full-Time

Associate Director

Posted on 4/18/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulation technologies for diseases

Biotechnology

Compensation Overview

$181,000 - $213,000Annually

Senior

Menlo Park, CA, USA

Requirements
  • Technical expertise in solid oral dose formulations for small molecules
  • Hands-on experience in formulating drugs with limited solubility
  • Experience in formulation and process development from early to late phase development
  • Understanding of ICH, FDA, EMA guidance in CMC and Quality areas
  • Working knowledge of GMP requirements for drug product development and manufacturing
  • Experience in writing CMC sections of regulatory filings
  • Strong written and oral communication skills
  • Project management and leadership skills
  • Experience in managing outsourced drug product development activities
Responsibilities
  • Design and select appropriate formulations for toxicology and first in human studies
  • Support formulation and process development, technology transfer, and clinical manufacturing activities
  • Develop strategies and execute plans for drug product development
  • Select and manage contract development and manufacturing vendors
  • Negotiate and approve statements of work and quotes
  • Review and approve manufacturing documents, protocols, and reports
  • Work closely with other internal functional groups to ensure drug product requirements for clinical trials are met
  • Work closely with QA to ensure clinical supplies meet quality requirements
  • Prepare CMC sections of regulatory filings
  • 15-20% travel expected

Corcept Therapeutics specializes in developing selective glucocorticoid receptor antagonists to address the adverse effects of excess cortisol in a range of diseases, with a primary emphasis on creating a new generation of compounds aimed at mitigating the effects of excess cortisol in various diseases. Their focus is on cortisol modulation technologies for endocrine, metabolic, oncologic, and psychiatric disorders, with a pipeline of over 30 ongoing studies.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

8%

1 year growth

20%

2 year growth

38%